TY - JOUR
T1 - A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures
AU - Goal, Oliver Ethan
AU - Amanda, Isca
AU - Adams, Cameron
AU - Grando, Maria Adela
N1 - Publisher Copyright:
© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2025
Y1 - 2025
N2 - Introduction: : There is a need to assess the delivery of interventions to improve substance use disorder (SUD) treatment, as measured by the Healthcare Effectiveness Data and Information Set (HEDIS®) metrics. The goal was to characterize published articles reporting HEDIS® SUD measures and recommend future work on applying and investigating SUD HEDIS® metrics and their effect on SUD treatments. Materials and Methods: The PRISMA-ScR scoping review protocol was used to find published work and investigate the most common reported baseline characteristics, HEDIS® metric outcomes, and knowledge gaps. Peer-reviewed papers available through PubMed, Academic Search Premier, Elsevier/ScienceDirect, and Medline were searched up to August 14, 2022. Results: : Twenty-eight articles were included after removing 92 duplications. Twenty-five articles were retrospective cohort studies, two were RCTs, and there was a mixed-method study. SUD metrics were studied in diverse settings, including ED, primary care, mental health care, and SUD specialty care. Twenty-seven papers utilized the Initiation and Engagement of Substance Use Disorder Treatment (IET) measure, and 13 had similar data sources, study populations, and authors. Eight papers presented IET results by substance used, primarily alcohol, cannabis, and opioids. Conclusions: : More research is needed on the HEDIS® SUD metrics and their usefulness in informing SUD prevention and treatment, policy, and public health outcomes.
AB - Introduction: : There is a need to assess the delivery of interventions to improve substance use disorder (SUD) treatment, as measured by the Healthcare Effectiveness Data and Information Set (HEDIS®) metrics. The goal was to characterize published articles reporting HEDIS® SUD measures and recommend future work on applying and investigating SUD HEDIS® metrics and their effect on SUD treatments. Materials and Methods: The PRISMA-ScR scoping review protocol was used to find published work and investigate the most common reported baseline characteristics, HEDIS® metric outcomes, and knowledge gaps. Peer-reviewed papers available through PubMed, Academic Search Premier, Elsevier/ScienceDirect, and Medline were searched up to August 14, 2022. Results: : Twenty-eight articles were included after removing 92 duplications. Twenty-five articles were retrospective cohort studies, two were RCTs, and there was a mixed-method study. SUD metrics were studied in diverse settings, including ED, primary care, mental health care, and SUD specialty care. Twenty-seven papers utilized the Initiation and Engagement of Substance Use Disorder Treatment (IET) measure, and 13 had similar data sources, study populations, and authors. Eight papers presented IET results by substance used, primarily alcohol, cannabis, and opioids. Conclusions: : More research is needed on the HEDIS® SUD metrics and their usefulness in informing SUD prevention and treatment, policy, and public health outcomes.
KW - HEDIS metrics
KW - Scoping review
KW - addiction
UR - https://www.scopus.com/pages/publications/85214029187
UR - https://www.scopus.com/pages/publications/85214029187#tab=citedBy
U2 - 10.1080/07853890.2024.2447413
DO - 10.1080/07853890.2024.2447413
M3 - Review article
C2 - 39745202
AN - SCOPUS:85214029187
SN - 0785-3890
VL - 57
JO - Annals of Medicine
JF - Annals of Medicine
IS - 1
M1 - 2447413
ER -